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Modified nucleotides at the 5 end of human U2 snRNA
are required for spliceosomal E-complex formation
GIZEM DÖNMEZ, KLAUS HARTMUTH, and REINHARD LÜHRMANN
Department of Cellular Biochemistry, Max Planck Institute of Biophysical Chemistry, D-37077 Göttingen, Germany
ABSTRACT
U2 snRNA, a key player in nuclear pre-mRNA splicing, contains a 5-terminal m3G cap and many internal modifications. The
latter were shown in vertebrates to be generally required for U2 function in splicing, but precisely which residues are essential
and their role in snRNP and/or spliceosome assembly is presently not clear. Here, we investigated the roles of individual
modified nucleotides of HeLa U2 snRNA in pre-mRNA splicing, using a two-step in vitro reconstitution/complementation assay.
We show that the three pseudouridines and five 2O-methyl groups within the first 20 nucleotides of U2 snRNA, but not the
m3G cap, are required for efficient pre-mRNA splicing. Individual pseudouridines were not essential, but had cumulative effects
on U2 function. In contrast, four of five 2O-methylations (at positions 1, 2, 12, and 19) were individually required for splicing.
The in vitro assembly of 17S U2 snRNPs was not dependent on the presence of modified U2 residues. However, individual
internal modifications were required for the formation of the ATP-independent early spliceosomal E complex. Our data strongly
suggest that modifications within the first 20 nucleotides of U2 play an important role in facilitating the interaction of U2 with
U1 snRNP and/or other factors within the E complex.
Keywords: mRNA splicing; modified nucleotides; pseudouridine; ribose methylation; E complex
INTRODUCTION
The removal of introns from pre-mRNA is achieved by a
highly dynamic ribonucleoprotein complex termed the spli-
ceosome. It is formed by the ordered association of the U1,
U2, U4/U6, and U5 snRNPs (small nuclear ribonucleopro-
teins) and non-snRNP proteins with conserved regions of
the pre-mRNA at the 5 and 3 splice sites and the so-called
branch site (for review, see Reed and Palandijan 1997;
Burge et al. 1999). The first step of spliceosome assembly
includes the ATP-independent recognition of the 5 splice
site by U1 snRNP, forming the E (early) complex. In an
ATP-requiring step, U2 snRNA then base-pairs with the
branchsite, generating the pre-spliceosome or A complex.
Subsequently, the U4/U6.U5 tri-snRNP binds, giving rise to
the B complex. After major RNA–RNA rearrangements, the
catalytically activated spliceosome is formed. During these
rearrangements, the U4 and U6 snRNAs dissociate and the
5 end of U2 enters into base-pairing interactions with U6,
forming part of the spliceosome’s catalytic core. The acti-
vated spliceosome catalyses the first transesterification step
of splicing and complex C is formed. After the second step
of splicing, the mRNA is released and the post-spliceosomal
complex, containing the excised intron and the U2, U5, and
U6 snRNPs, disassembles and the snRNPs are then recycled
for new rounds of splicing. U2 snRNA thus plays an active
role during nearly all stages of the splicing process. Indeed,
purified E complexes were recently shown to contain both
U1 and U2 snRNPs, indicating that U2 may play an im-
portant role already during the earliest steps of intron rec-
ognition (Das et al. 2000). However, the role of U2 snRNP
components in E-complex formation is largely unknown.
The protein composition of the human 17S U2 snRNP is
well characterized. It contains the seven Sm proteins, com-
mon to U1, U2, U4, and U5, the stably associated U2-
specific A and B polypeptides, and the splicing-essential
SF3a and SF3b heteromeric protein complexes (for review,
see Krämer 1996; Das and Reed 1999; Krämer et al. 1999;
Will et al. 2001). SF3a and SF3b facilitate the interaction of
U2 with the branch site (Gozani et al. 1996; Das et al. 1999;
Will et al. 2001). Recently, a number of additional proteins,
including Prp5, Prp43, SPF30/SMNrp, SPF31, and SPF45
were identified in purified 17S U2 snRNPs (Will et al.
2002); these proteins were also found in purified human
pre-spliceosomes (Hartmuth et al. 2002).
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Of the U snRNAs, U2 has the most post-transcriptional
internal modifications. Human U2 snRNA (Fig. 1) contains
ten 2O-methylated (2O-Me) residues and 13 pseudouri-
dines (5--D-ribofuranosyluracil). The synthesis of most of
these modifications is directed by sequence-specific guide
RNAs in the nucleoplasmic Cajal bodies following import of
U2 from the cytoplasm (Jády et al. 2003). In U snRNAs,
most modified nucleotides are found in regions of func-
tional importance (for review, see Gu et al. 1996). For ex-
ample, almost all modified bases of U2 are found in its 5
half (Fig. 1). Additionally, spliceosomal U snRNAs, except
U6, obtain cotranscriptionally at their 5 end an m7G cap,
which is converted to m3G in the cytoplasm and serves as a
signal for reimport of the U snRNPs into the nucleus
(Fischer and Lührmann 1990; Hamm et al. 1990).
Neither the m3G cap nor internal modifications are es-
sential for the function of U1 (Will et al. 1996), U4 (Wersig
and Bindereif 1992), U5 (Ségault et al. 1995), or U6 (Wolff
and Bindereif 1992) snRNAs in splicing in vitro. In contrast,
post-transcriptional modifications are essential for U2 func-
tion in Xenopus oocytes (Pan and Prives 1989) and HeLa
nuclear extract (Ségault et al. 1995), but their role remains
poorly understood. Modifications within the first 27
nucleotides of U2 snRNA, including the m3G cap, were
shown to be required for splicing and/or U2 snRNP bio-
genesis in Xenopus oocytes (Yu et al. 1998). More recent
data suggest a role for pseudouridines in and near the
branchsite-binding sequence of U2 in splicing/U2 assembly
(Zhao and Yu 2004).
Here, we investigate the roles of individual modified
nucleotides of HeLa U2 snRNA in pre-mRNA splicing. We
used a two-step reconstitution/complementation system
that generates mature U2 snRNP particles from U2 snRNAs
containing a given number of modified residues. We dem-
onstrate that the three pseudouridines and five 2O-methyl
groups within the first 24 nucleotides of HeLa U2 snRNA
are to various degrees required for pre-mRNA splicing. In
contrast, the 5 m3G cap is dispensable. Further, we show
that modified bases in U2 snRNA are not required for 17S
U2 snRNP assembly in vitro, but rather are essential for
E-complex formation.
RESULTS
Experimental system for depletion/
complementation assays
To explore the roles of individual internal modified nucleo-
tides within the 5 end of U2 snRNA in splicing, we chemi-
cally synthesized RNA oligonucleotides corresponding to
the 5-terminal 24 nucleotides of U2, which contained dif-
fering numbers and types of modifications (Fig. 2A). These
were ligated to an unmodified in vitro transcript encom-
passing the remaining nucleotides of U2, resulting in chi-
maeric U2 snRNA molecules. A total of 17S U2 snRNPs
were then reconstituted by first assembling core U2 snRNPs
from RNA-free, purified Sm proteins and U2 snRNA, and
subsequently adding nuclear extract depleted specifically of
core U2 snRNP (Ségault et al. 1995). Splicing activity of the
reconstituted U2 snRNPs was then assayed by addition of
32P-labeled pre-mRNA and incubation for 3 h at 30°C (Fig.
2B). The splicing activity of mock-depleted nuclear extract
(Fig. 2B, lane 3) was comparable to untreated nuclear ex-
tract (Fig. 2B, lane 2). In contrast, U2-depleted nuclear
extract was no longer active in splicing (Fig. 2B, lane 4).
Reconstituted U2 snRNPs containing U2 snRNA purified
from HeLa U2 snRNPs (Fig. 2B, lane 5) restored splicing
to the level of mock-depleted nuclear extract. Consistent
with earlier results (Ségault et al. 1995), reconstituted U2
snRNPs containing in vitro transcribed U2 failed to
complement splicing (Fig. 2B, lane 6). In the absence of
functionally active U2 snRNPs, the pre-mRNA was appar-
ently more readily degraded in nuclear extract under splic-
ing conditions (e.g., cf. Fig. 2B lanes 4,6 and 3,5).
FIGURE 1. Primary and secondary structure of human U2 snRNA. (m3G) N
2,2,7-trimethylguanosine; (m) 2O-methyl; () pseudouridine;
(m6) N6-methyl. The Sm site and branchpoint recognition sequences are indicated. Stem loops are numbered with roman numerals.
Dönmez et al.
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Internal modifications at the 5 end of U2 snRNA,
but not the m3G cap structure, are required for
splicing in vitro
We next tested whether modifications at the 5 end of U2
are generally required for splicing. As observed with U2
transcript (Fig. 2B, lane 6), a chimaeric U2 snRNA lacking
any modification (m-U2 snRNA) was found to be in-
active in splicing (Fig. 2B, lane 7). In contrast, the m-U2
snRNA, which contains all 2O-methylated and pseudouri-
dine residues within the first 24 nucleotides, but lacks an
m3G cap, complemented splicing almost as efficiently as
HeLa U2 snRNA (Fig. 2B, cf. lanes 5 and 8). Importantly,
HeLa nuclear extract on its own does not support pseudo-
uridylation of chimaeric RNAs m and m under a va-
riety of conditions assayed (Fig. 3A). This is consistent with
the previous results where pseudouridine was not detected
in in vitro-transcribed U2 snRNA after in vitro reconstitu-
tion and splicing (Ségault et al. 1995). Furthermore, during
reconstitution and splicing, no selective degradation of
m or three other tested U2 snRNAs was observed (Fig.
3B, lanes 1–4). Thus, internal modifications have no sig-
nificant effect on the stability of U2 snRNA in nuclear ex-
tract. Taken together, we conclude that only the internal
modifications present in m-U2 snRNA, namely those
within the first 24 nucleotides, functionally contribute to
splicing complementation in our in vitro system, while the
m3G cap is dispensable.
The three pseudouridines within the first 24
nucleotides contribute to U2 snRNA function
in splicing
We next investigated the contribution of individual pseu-
douridines to splicing complementation (Fig. 2B). A U2
FIGURE 2. Internal modifications in the first 24 nucleotides of U2
snRNAs are required for splicing. (A) The sequence composition of
the chemically synthesized oligonucleotides corresponding to the first
24 nucleotides of U2 snRNA. The following notation is used: m,
replacement of all pseudouridines () by uridines (U) and deletion of
all 2O-methylations (2O-Me); (m) retention of all  and 2O-Me;
() replacement of alls by U; (n) replacement of at position
n with U; (m) deletion of all 2O-Me; (mn) deletion of 2O-Me at
position n. The oligonucleotides were ligated to in vitro-transcribed
U2 starting at G25. For comparison, sequences of purified HeLa U2
and U2 transcript are shown. (B) Internal modifications within the
first 24 nucleotides of U2 snRNA are required for efficient comple-
mentation of splicing. Splicing complementation of U2 snRNAs dif-
fering in the number and type of internal modifications was assayed
in the two-step reconstitution system by monitoring splicing of 32P-
labeled pre-mRNA (lane 1). Untreated (lane 2), mock-depleted (lane
3), and U2-depleted (lane 4) nuclear extract are shown as controls.
(Lanes 5–18) Complementation of U2-depleted nuclear extract with
U2 snRNPs reconstituted with the U2 snRNA indicated above each
lane. RNA was analyzed by denaturing PAGE and visualized by au-
toradiography. FIGURE 3. Chimaeric U2 snRNAs are not pseudouridylated and re-
main stable during reconstitution and splicing in the HeLa cell nuclear
extract. (A) Chimaeric U2 RNAs m (lanes 1,2) and m (lanes 3,4)
bearing internal 5[32P]U labels downstream of G25 were treated with
nuclease P1 before (lanes 1,3) or after reconstitution and splicing
(lanes 2,4) and analyzed by TLC on PEI plates. The position of uridine
5-monophosphate (pU) is indicated. Pseudouridine 5-monophos-
phate (p) would be expected at the position indicated by square
brackets. (B) Internal RNA modifications do not differentially affect
the stability of U2 snRNP in nuclear extract. Equivalent amounts of
four different 3 end-labeled chimaeric U2 snRNAs (indicated above
the panels) were analyzed before (top) and after (bottom) an in vitro
splicing complementation reaction, using unlabeled pre-mRNA.
A role of U2 snRNA modifications in splicing
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snRNA in which all pseudouridines within the first 24
nucleotides are replaced by uridines, but the 2O-methyl
groups are retained [-U2 did not support splicing (Fig.
2B, lane 9)], demonstrating that one or more of these pseu-
douridines is required for splicing. However, when indi-
vidual pseudouridines at positions 6, 7, or 15 were replaced
by uridines, generating the 6-U2, 7-U2, and 15-
U2 snRNAs, splicing activity was significantly reduced, as
compared with HeLa U2 orm-U2, but not abolished (Fig.
2B, lanes 10–12). Thus, individual pseudouridines are not
absolutely required for splicing complementation, but con-
tribute to U2 function. The inactivity of the -U2 snRNA
thus arises from the cumulative effect of the loss of indi-
vidual pseudouridines at positions 6, 7, or 15 of U2 snRNA.
Four 5-terminal 2O-methylations are essential for
the function of U2 snRNA in pre-mRNA splicing
To investigate the role of 2O-methylations, we performed
reconstitution/complementation studies with chimaeric U2
snRNAs lacking one or more 2O-methyl groups. A U2
snRNA lacking all five 2O-methyl groups, but containing
pseudouridines (m-U2), was inactive in splicing (Fig. 2B,
lane 13). Chimaeric U2 snRNAs lacking individual 2O-
methyl groups at positions 1, 2, 12, or 19 (i.e., m1-U2,
m2-U2, m12-U2, and m19-U2) also failed to comple-
ment splicing activity (Fig. 2, lanes 14,15,17,18). In contrast,
deletion of the 2O-methyl of nucleotide G11 reduced, but
did not abolish, splicing (Fig. 2, lane 16). Thus, 2O-methyl
groups at positions 1, 2, 12, and 19, but not at position 11,
are individually required for the function of U2 snRNA in
pre-mRNA splicing.
Internal modifications at the 5 end of U2 snRNA
are required for E-complex formation
To determine whether modified U2 nucleotides act prior to
the catalytic steps of splicing, we next investigated whether
they affect spliceosome assembly. For this purpose, we per-
formed splicing in the presence of ATP and analyzed A-
complex formation on agarose gels (Das and Reed 1999).
HeLa and m-U2 snRNA supported A-complex formation
as efficiently as untreated and mock-depleted nuclear ex-
tract (Fig. 4A, cf. lanes 4,7 and lanes 1,2). In contrast, no A
complex could be detected with U2-depleted extract or
upon complementation with any of the other U2 snRNAs
(Fig. 4A, lanes 3,8–17). The apparent lack of A-complex
formation with the 6-U2, 7-U2, 15-U2, and
m11-U2 snRNAs was unexpected, as low levels of splicing
activity had been observed with these snRNAs (Fig. 2B).
However, A complexes formed with these U2 chimera could
have escaped detection either due to their inherent insta-
bility during gel electrophoresis or due to fast turnover of
the low amounts formed. These data indicate that indi-
vidual 2O-methyl groups at positions 1, 2, 12, and 19, and
collectively pseudouridines at positions 6, 7, and 15, are
required either prior to or at the time of A-complex for-
mation.
To determine whether internal modifications are re-
quired at an earlier step, we next performed splicing in the
absence of ATP (see Introduction) and assayed E-complex
formation (Fig. 4B). In contrast to mock-depleted extract,
U2-depleted nuclear extract on its own did not support
E-complex assembly (Fig. 4B, lane 3), corroborating the
requirement for U2 snRNP during this process (Das et al.
2000). HeLa and m-U2 snRNA supported E-complex as-
FIGURE 4. Internal modifications within the first 24 nucleotides of
U2 snRNA are required for efficient spliceosome assembly. Analysis
of A-complex (A) and E-complex (B) formation with chimaeric U2
snRNAs. Untreated (lane 1), mock-depleted (lane 2), and U2-depleted
(lane 3) nuclear extract are shown as controls. (Lanes 4–17, each
panel) Complementation of the U2-depleted nuclear extract with U2
snRNPs reconstituted with the U2 snRNA indicated above each lane.
Positions of the H, A, and E complexes are indicated. The ATP deple-
tion of nuclear extract for the E-complex assay (B) was complete, as no
A complex could be detected when control samples were analyzed in
the presence of heparin (data not shown). Complexes were analyzed
on native agarose gels and visualized by autoradiography.
Dönmez et al.
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sembly as efficiently as untreated or
mock-depleted nuclear extract (Fig. 4B,
cf. lanes 4,7 and lanes 1,2). U2 tran-
script or m-U2 snRNA (Fig. 4B,
lanes 5,6) on the other hand, did not
support E-complex assembly, suggest-
ing that at least some of the modifica-
tions are required for U2 function at
this assembly stage. U2 snRNPs recon-
stituted from the 6-U2, 7-U2,
15-U2, and m11-U2 snRNAs
formed E complex, albeit less efficiently
than HeLa or m-U2 (Fig. 4B, lanes
9–11,15), consistent with their reduced
splicing activity (Fig. 2B). All other 2O-
methyl deletions (Fig. 4B, lanes 13,14,
16,17) abolished E-complex formation,
demonstrating that these modifications
are individually required for E-complex
formation.
Modifications are not required
for the association of 17S
U2-specific proteins
The inability of certain U2 snRNA chi-
maera lacking modified nucleotides to
support E-complex formation could be
due to inhibition of U2 snRNP assem-
bly. We therefore investigated whether 17S U2 snRNP for-
mation is compromised in the absence of modifications. U2
snRNPs were thus reconstituted with 32P-labeled HeLa
snRNA or U2 transcript and analyzed by glycerol gradient
centrifugation. U2 snRNPs assembled with either RNA
peaked in the 17S region of the gradient (fractions 13–17;
Fig. 5A) and no apparent difference in their distribution
across the gradient could be detected. These results pro-
vided a first indication that neither internal modifications
nor the m3G cap are required for 17S U2 snRNP assembly.
However, the reconstituted 17S U2 snRNPs could poten-
tially lack one or (Behrens et al. 1993; Will et al. 2002) more
U2-specific protein, which would not necessarily be detect-
able by sedimentation analysis (cf. Will et al. 2002). Thus,
U2 snRNP formation was additionally assayed by immuno-
precipitation with antibodies against a subset of U2 snRNP-
specific proteins. As expected, both fully modified and un-
modified U2 snRNAs were precipitated with anti-Sm (Fig.
5B, lanes 6,12) and anti-U2 B (data not shown) antibodies,
indicating that 12S U2 snRNP formation is not dependent
on modifications. In addition, both RNAs were precipitated
by SF3a66 (Fig. 5B, lanes 2,8) and SF3b155 (Fig. 5B, lanes
4,10) antibodies. As SF3a66 and SF3b155 are components
of the highly stable heteromeric SF3a and SF3b protein
complexes, respectively, it is highly likely that all subunits of
SF3a and SF3b are present. Thus, consistent with the ob-
served sedimentation behavior of reconstituted U2 snRNPs,
association of these complexes with U2 snRNA does not
require modifications. Further, when immunoprecipitations
were performed with antibodies against SPF30/SMNrp,
SPF31, and hPrp5, which are substoichiometrically present
in 17S U2 snRNPs (Fig. 5C), no significant difference in
precipitation efficiency was observed between HeLa U2
snRNA and U2 transcript. Taken together, we conclude that
U2 snRNA modifications are not required for the formation
of intact 17S U2 snRNPs.
DISCUSSION
In this report, we show that efficient pre-mRNA splicing in
vitro is dependent on the three pseudouridines and the five
2O-methyl groups within the first 24 nucleotides of U2
snRNA. In contrast, neither the m3G cap nor internal modi-
fications downstream of A24 are required. Moreover, we
could show that the internal modifications at the 5 end of
U2 snRNA are not required for 17S U2 snRNP formation in
vitro (see also below). Strikingly, all internal modifications
required for splicing were also shown to be essential for the
ATP-independent formation of spliceosomal E complexes.
Our data thus corroborate previous observations, indicating
that U2 snRNP is functionally associated with the pre-mRNA
already in the E complex (Das et al. 2000), and show for the
FIGURE 5. 17S U2 snRNP assembly is not dependent on the presence of modifications in U2
snRNA. (A) Both HeLa U2 snRNA (top) and U2 transcript (bottom) assemble into a 17S U2
snRNP in vitro. The 3 end-labeled RNAs were used for two-step reconstitution and RNPs were
analyzed on a 10%–30% glycerol gradient. The RNA content of the odd fractions was analyzed
by denaturing PAGE and visualized by autoradiography. Native 17S U2 snRNP, isolated ac-
cording to Will et al. (2002), exhibited an identical sedimentation behavior (data not shown).
(B,C) Immunoprecipitation assays of U2 snRNPs reconstituted with 3 end-labeled HeLa U2
snRNA (B, lanes 1–6, C, lanes 1–7) or U2 transcript (B, lanes 7–12, C, lanes 8–14). The antibody
used is indicated above each lane. (NIS) Nonimmune serum of the antibody in the preceeding
lane. Antibodies denoted with * were affinity purified. Major (B) and substoichiometric (C)
components of U2 snRNP were analyzed.
A role of U2 snRNA modifications in splicing
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first time that internal modifications within the first 24
nucleotides of U2 are required for this functional interac-
tion.
Data presented here regarding the function of the U2
snRNA’s 5 m3G-cap indicates that the cap does not play a
differential role in the function/assembly of the major spli-
ceosomal U snRNAs (i.e., U1, U2, U4, and U5). In all cases,
the cap is dispensable for their activity in splicing and also
for their assembly in vitro (see Introduction). We note that
the results obtained with U2 snRNPs reconstituted in HeLa
nuclear extract differ somewhat from those observed with
Xenopus oocytes (Yu et al. 1998; Zhao and Yu 2004). In the
latter experiments, pseudouridines, and to some extent, also
the m3G cap structure, were found to be critical for the
assembly in the nucleus of a stable 17S U2 snRNP particle.
This could either be due to species-specific differences or to
differential requirements of 17S U2 snRNP assembly in vivo
versus in vitro.
Our analysis of the contribution of individual modifica-
tions to splicing allowed us to clearly distinguish between
the effects of pseudouridines and 2O-methylations. When
individual pseudouridines at positions 6, 7, and 15 of U2
snRNA were replaced by uridines, residual E-complex for-
mation and splicing was observed. However, substitution of
all pseudouridines by uridines resulted in a complete loss of
splicing (Fig. 2B). These results thus provide evidence for a
cumulative effect of pseudouridines on E-complex forma-
tion and splicing. In contrast, four of the five 2O-methyl-
ations within the 5-terminal 24 nucleotides of U2 snRNA
were absolutely required for E-complex formation and
splicing; only deletion of the 2O-methyl at G10 was not
completely detrimental to splicing (Fig. 2B).
Our finding that as many as eight modifications within a
short stretch of 24 nucleotides of U2 snRNA are either
essential or contribute significantly to U2 function is quite
surprising considering that post-transcriptional modifica-
tions in many RNA molecules often have no significant
effect on their function, at least not when tested in vitro (for
review, see Charette and Gray 2000). Some cases, where
modifications have been documented to be required for
RNA function, are known, however. For example, post-
transcriptional modifications in the primer tRNA3
Lys are
required for initiation and elongation of HIV1 reverse tran-
scription (Isel et al. 1993). Whereas it is thought that the
initiation of the reverse transcriptase with the priming com-
plex is affected (Isel et al. 1996), the contribution of indi-
vidual modified residues of tRNA3
Lys to the functional in-
teraction with the reverse transcriptase remains to be inves-
tigated. Another example is the selective translational
activation of stored maternal mRNAs during early matura-
tion of Xenopus oocytes. Here, 2O-methylation of the first
two bases, that is, the synthesis of a cap II structure on
dormant maternal mRNAs, was shown to be required for
translational activation (Kuge and Richter 1995; Kuge et al.
1998). The exact function of the two methyl groups in this
activation process is not yet understood. Finally, modified
nucleotides that are clustered in the peptidyl transferase
center of the 23S and 28S rRNAs of the large subunits of
Escherichia coli and yeast ribosomes, respectively, also ap-
pear to be required for efficient translational activity of the
ribosome (Green and Noller 1996; King et al. 2003). The
effects of individual modified residues appear to be primar-
ily cumulative ones; only a single pseudouridine residue in
the peptidyltransferase center of yeast 28S rRNA was found
to contribute substantially on its own to translational effi-
ciency (King et al. 2003).
Why might pseudouridines and 2O-methylations in the
5-terminal region of U2 snRNA be required for U2 snRNP
function in E-complex formation and splicing? One of the
few well-established roles of pseudouridine is that it stabi-
lizes the conformation of RNA by base stacking, with an
approximately additive effect on stability when multiple
pseudouridines are present (Meroueh et al. 2000), and by
coordinating a structural water molecule between its addi-
tional hydrogen bond donor at N1-H and the phosphate
backbone (Arnez and Steitz 1994). Similarly, 2O-methyl-
ation is a powerful biological means to stabilize an RNA
helix (for review, see Davies 1998). Thus, one explanation
would be that both requirements are a reflection of the
necessity for a stabilized U2 5 stem loop structure during
E-complex formation.
In addition to stabilizing RNA structure, modifications
could also play a role in RNA–protein interactions, and thus
in this way, be of functional importance for either U2 snRNP
structure or E-complex assembly. However, several obser-
vations do not support a structural role for modifications in
the architecture of U2 snRNP. First, modifications were not
required for in vitro assembly of a 17S U2 snRNP particle,
and their absence had no detectable effect on the association
pattern of most U2 snRNP-specific proteins with the U2
snRNA, as evidenced by immunoprecipitation analyses (Fig.
5B,C). Second, although we observed a number of protein–
RNA cross-links between U2-specific proteins and the 5
region of U2 snRNA in purified HeLa 17S U2 snRNPs, these
cross-links were not found to be dependent on the presence
of modifications when U2 snRNPs were reconstituted
in our two-step in vitro system (O. Dybkov, G. Do¨nmez, K.
Hartmuth, C. Will, and R. Lührmann, unpubl.). Whereas
these arguments are not decisive and we cannot rigorously
exclude the possibility that U2 snRNA modifications play a
role in fine tuning RNA–protein interactions within the 17S
U2 snRNP, we favor the idea that modified nucleotides
contribute functionally first at the time of E-complex for-
mation. It will therefore be interesting in the future to in-
vestigate how U2 snRNP communicates with U1 snRNP
and/or other essential factors in the E complex and whether
5-terminal U2 modifications facilitate RNA–RNA or pro-
tein–RNA interactions between U2 snRNP and other E-
complex components. These interactions could also involve
components of the U4/U6.U5 tri-snRNP complex, as the
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latter has been reported to contribute to recognition of the
5 splice site at an early step of spliceosome assembly (Ma-
roney et al. 2000). Our demonstration in this study that
functionally active U2 snRNPs can be reconstituted in vitro
from chimaeric U2 snRNAs, which, in addition, may also
contain reporter molecules, including those useful for
cross-linking or hydroxyl radical probing, will considerably
facilitate such studies.
MATERIALS AND METHODS
Materials
DNA oligonucleotides used:
K78: 5-CCTAATACGACTCACTATAGATCGCTTCTCGGCCTT
TTGGC-3;
K79: 5-GCCATGCTCGAGGGTGCACCGTTCCTGGAGGTAC-3;
K80: 5-GTATCAGATATTAAACTGATAAGAACAGATACTACA
CTTGATCTTAGCCAAAAGGCCGAGAAGCGAT-3;
K82: 5-CCTAATACGACTCACTATAGATCAAGTGTAGTATCT
GTTCTTATC-3.
RNA oligonucleotides were purchased from Dharmacon (USA) or
RNA-Tec (Belgium). The bU2 biotinylated 2O-methylated oligo-
nucleotide, complementary to nucleotides 1–20 of U2 snRNA,
(Ségault et al. 1995) was obtained from RNA-Tec. The following
antibodies were used: anti-SF3a66, anti-hPrp5 (Will et al. 2002);
anti-SF3b155 (Will et al. 2001); anti-Sm (Y12, Lerner and Steitz
1979), anti-U2 B (4G3, Habets et al. 1989), and anti-SPF30 (Meis-
ter et al. 2001). Anti-SPF31 antibodies were raised against a pep-
tide (amino acids 1–17) of the SPF31 protein. Where appropriate,
nonimmune serum (NIS) was used as a negative control. Peptide
antibodies were affinity purified as described previously (Will et al.
2002).
Preparation and analysis of RNA
DNA templates for in vitro transcription of U2 snRNA constructs
were prepared by PCR amplification of pMRG3U2-27 (Jacobson
et al. 1993) using primers K78/K79 (U2 snRNA) or primers K82/
K79 (G25-U2 snRNA, starting at nucleotide G25), and cleaved
with XhoI. Large-scale T7 RNA polymerase transcription was per-
formed as previously described (Milligan and Uhlenbeck 1989).
All RNAs were purified on 9.6% polyacrylamide-8.3 M urea gels.
HeLa U2 snRNA was prepared by gel fractionation of a HeLa 5S
RNA fraction prepared from HeLa cell nuclear extract by phenol
extraction and fractionation. The 3-end labeling of RNA was
performed as described (England and Uhlenbeck 1978). The G25-
U2 snRNA transcript was first dephosphorylated, then 5-phos-
phorylated with polynucleotide kinase and subsequently 3 end-
labeled. Chimaeric U2 snRNAs were prepared by mixing the re-
spective RNA oligonucleotide with the G25-U2 snRNA and K80
splint oligonucleotide, and then ligating with T4 DNA ligase
(Moore and Sharp 1992). Full-length chimaeric U2 snRNAs were
gel purified and 32P-labeled RNAs were visualized either by auto-
radiography or with a PhosphorImager (Typhoon, Amersham
Biosciences).
U2 snRNP depletion and in vitro reconstitution
HeLa cell nuclear extracts (Dignam et al. 1983) were depleted of
U2 snRNPs by affinity selection with bU2 oligonucleotide and
streptavidin agarose beads essentially as described previously
(Ségault et al. 1995), except that oligonucleotide was used at a
concentration of 8 nmol/mL and extract was dialyzed against Dig-
nam’s buffer D (Dignam et al. 1983) without glycerol. Mock-
depleted extract was prepared in an identical manner, except that
oligonucleotide was omitted. U2 snRNP reconstitution was carried
out essentially as described by Ségault et al. (1995). Briefly, 2.4
pmol of the various U2 snRNAs were first reconstituted with 1.9
µg total snRNP proteins in a volume of 12 µL. A 14 µL splicing
complementation reaction without pre-mRNA (see below) was
then prepared and incubated for 30 min at 0°C. This mixture was
used either directly for RNP analysis, or after addition of MINX
pre-mRNA (Wolff and Bindereif 1992), for splicing complemen-
tation.
In vitro splicing and spliceosomal complex assays
Splicing complementation assays (15 µL) contained 40% nuclear
extract, 6.7% (1 µL) U2 snRNP, 2.4 mM MgCl2, 60 mM KCl,
2 mM ATP, 20 mM creatine phosphate, and 50 fmol (1 µL)
32P-labeled pre-mRNA. To analyze splicing of the pre-mRNA,
reactions were incubated for 3 h at 30°C. RNA was purified and
analyzed on a 15% polyacrylamide-8.3 M urea gel. For E-complex
analysis, nuclear extract was first depleted of ATP as described by
Das and Reed (1999). Splicing assays (lacking ATP) were then
incubated for 10 min at 30°C and 3 µL of 4% sucrose (w/v)
containing tracking dyes (loading buffer) were added to a 7 µL
aliquot of the splicing reaction. To analyze A-complex formation,
splicing was performed as described for E complex, except ATP
was added and loading buffer containing 0.2 mg/mL heparin sul-
phate was subsequently added. Samples were analyzed on a 1.5%
low-melting agarose gel (Das and Reed 1999).
Pseudouridine modification assay
The chimaeric m and m-U2 RNAs were prepared as de-
scribed above, except that a [32P]UTP G25-U2 snRNA transcript
was used and 3 end labeling was omitted. After U2 snRNP re-
constitution, reaction mixtures were incubated for 3 h at 30°C
under splicing conditions. The RNA was purified and then resus-
pended in 5 µL of 20 mM sodium acetate (pH 5.2) containing
nuclease P1 of 200 µg/mL, and then incubated at 37°C for 90 min.
Samples were chromatographed on cellulose PEI plates as de-
scribed (Ségault et al. 1995) and plates were autoradiographed.
Glycerol gradient centrifugation and
radioimmunoprecipitation assays
In vitro reconstituted U2 snRNP (140 µL) was prepared with 3
end-labeled HeLa U2 snRNA or U2 transcript and fractionated on
a 10%–30% glycerol gradient (Will et al. 2002). RNA from the odd
fractions was purified and analyzed on a 9.6% polyacrylamide-8.3
M urea gel. Immunoprecipitations were performed as described by
Will at al. (2002), using 14 µL of in vitro reconstituted U2 snRNPs
A role of U2 snRNA modifications in splicing
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(see above) per assay and 150 mM NaCl in all buffers. Bound RNA
was isolated and analyzed as described above.
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